Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma

NCT02743429 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: dinutuximab beta

Sponsor

University Medicine Greifswald

Collaborators

[object Object]